{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T19:54:19Z","timestamp":1781812459092,"version":"3.54.5"},"reference-count":8,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2022,12,7]],"date-time":"2022-12-07T00:00:00Z","timestamp":1670371200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,12,7]],"date-time":"2022-12-07T00:00:00Z","timestamp":1670371200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["OBES SURG"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1007\/s11695-022-06376-3","type":"journal-article","created":{"date-parts":[[2022,12,7]],"date-time":"2022-12-07T02:02:51Z","timestamp":1670378571000},"page":"676-681","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Endoscopic Bariatric Therapies for the Management of Obesity in Patients with Inflammatory Bowel Disease"],"prefix":"10.1007","volume":"33","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2838-0538","authenticated-orcid":false,"given":"Amanda M.","family":"Johnson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew C.","family":"Storm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tala","family":"Mahmoud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rabih","family":"Ghazi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Babusai","family":"Rapaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donna M.","family":"Abboud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr.","given":"Edward V.","family":"Loftus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barham K. Abu","family":"Dayyeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,12,7]]},"reference":[{"issue":"7","key":"6376_CR1","first-page":"350","volume":"16","author":"AM Johnson","year":"2020","unstructured":"Johnson AM, Loftus EV Jr. Impact of obesity on the management of inflammatory bowel disease. Gastroenterol Hepatol. 2020;16(7):350\u20139.","journal-title":"Gastroenterol Hepatol"},{"issue":"3","key":"6376_CR2","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/j.soard.2009.01.010","volume":"5","author":"SAGES Guidelines Committee","year":"2009","unstructured":"SAGES Guidelines Committee. Guidelines for clinical application of laparoscopic bariatric surgery. Surg Obes Relat Dis. 2009;5(3):387\u2013405.","journal-title":"Surg Obes Relat Dis"},{"issue":"6","key":"6376_CR3","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.1007\/s11695-017-3076-9","volume":"28","author":"S Aelfers","year":"2018","unstructured":"Aelfers S, Janssen IMC, Aarts EO, et al. Inflammatory bowel disease is not a contraindication for bariatric surgery. Obes Surg. 2018;28(6):1681\u20137.","journal-title":"Obes Surg"},{"issue":"8","key":"6376_CR4","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1093\/ibd\/izab249","volume":"28","author":"C Reenaers","year":"2021","unstructured":"Reenaers C, de Roover A, Kohnen L, et al. Bariatric surgery in patients with inflammatory bowel disease: a case-control study from the GETAID. Inflamm Bowel Dis. 2021;28(8):1198\u2013206. https:\/\/doi.org\/10.1093\/ibd\/izab249.","journal-title":"Inflamm Bowel Dis"},{"key":"6376_CR5","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.soard.2012.12.010","volume":"9","author":"JI Mechanick","year":"2013","unstructured":"Mechanick JI, Youdim A, Jones DB, et al. Clinical practice guidelines for the perioperative nutritional, metabolic, and nonsurgical support of the bariatric surgery patient: 2013 update \u2013 cosponsored by American Association of Clinical Endocrinologists, the Obesity Society, and American Society for Metabolic & Bariatric Surgery. Sur Obes Relat Dis. 2013;9:159\u201391.","journal-title":"Sur Obes Relat Dis"},{"issue":"3","key":"6376_CR6","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/j.gie.2015.03.1964","volume":"82","author":"BK Abu Dayyeh","year":"2015","unstructured":"ASGE Bariatric Endoscopy Task Force and ASGE Technology Committee, Abu Dayyeh BK, Kumar N, Edmundowicz SA, et al. ASGE Bariatric Endoscopy Task Force systematic review and meta-analysis assessing the ASGE PIVI thresholds for adopting endoscopic bariatric therapies. Gastrointest Endosc. 2015;82(3):425-38.e5.","journal-title":"Gastrointest Endosc"},{"issue":"6","key":"6376_CR7","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1016\/j.gie.2018.12.012","volume":"89","author":"A Alqahtani","year":"2019","unstructured":"Alqahtani A, Al-Darwish A, Mahmoud AE, et al. Short-term outcomes of endoscopic sleeve gastroplasty in 1000 consecutive patients. Gastrointest Endosc. 2019;89(6):1132\u20138.","journal-title":"Gastrointest Endosc"},{"issue":"2","key":"6376_CR8","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1016\/j.soard.2019.11.012","volume":"16","author":"S Singh","year":"2020","unstructured":"Singh S, de Moura Hourneaux DT, Khan A, et al. Safety and efficacy of endoscopic sleeve gastroplasty worldwide for treatment of obesity: a systematic review and meta-analysis. Surg Obes Relat Dis. 2020;16(2):340\u201351.","journal-title":"Surg Obes Relat Dis"}],"container-title":["Obesity Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11695-022-06376-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11695-022-06376-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11695-022-06376-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,31]],"date-time":"2023-01-31T16:30:47Z","timestamp":1675182647000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11695-022-06376-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,7]]},"references-count":8,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,2]]}},"alternative-id":["6376"],"URL":"https:\/\/doi.org\/10.1007\/s11695-022-06376-3","relation":{},"ISSN":["0960-8923","1708-0428"],"issn-type":[{"value":"0960-8923","type":"print"},{"value":"1708-0428","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,7]]},"assertion":[{"value":"18 July 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 November 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 November 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 December 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Given the nature of this study, formal consent is not required.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"AMJ, TM, RG, BR, DMA: No relevant conflicts of interest to disclose.ACS: Consulting for Apollo Endosurgery, GI Dynamics, Olympus, ERBE, and Intuitive and the recipient of research support from Apollo Endosurgery, Endo-TAGSS, Enterasense, Endogenex, and Boston Scientific.EVL: Consulting for AbbVie, Amgen, Arena, Boehringer Ingelheim, Bristol-Myers Squibb, Calibr, Celgene, Eli Lilly, Genentech, Gilead, Gossamer Bio, Iterative Scopes, Janssen, Morphic, Ono Pharma, Pfizer, Protagonist, Scipher Medicine, Sun Pharma, Surrozen, Takeda, and UCB and research support from AbbVie, Bristol-Myers Squibb, Celgene, Genentech, Gilead, Gossamer Bio, Janssen, Pfizer, Receptos, Theravance, Takeda, and UCB.BKA: Consulting for Endogenex, Endo-TAGSS, Metamodix, and BFKW; consultant and grant\/research support from USGI, Cairn Diagnostics, Aspire Bariatrics, and Boston Scientific; speaker roles with Olympus and Johnson and Johnson; speaker and grant\/research support from Medtronic, and Endogastric solutions; and research support from Apollo Endosurgery and Spatz Medical.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}